World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
99
Citations
41711
World Ranking
742
National Ranking
423

Medicine

D-Index
99
Citations
41859
World Ranking
8507
National Ranking
4389

Charles O. Elson publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Charles O. Elson sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 332 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Charles O. Elson D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Charles O. Elson sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 99 D-Index — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Charles O. Elson is affiliated with the University of Alabama at Birmingham in the United States. Their research primarily spans the fields of Medicine, Immunology and Microbiology, and Biochemistry, Genetics, and Molecular Biology. Within these domains, their work focuses heavily on Immunology, Genetics, Hematology, Oncology, and Epidemiology as subfields.

The scientist's research topics include:

  • T-cell and B-cell Immunology
  • Hematopoietic Stem Cell Transplantation
  • Immune Cell Function and Interaction
  • Inflammatory Bowel Disease
  • CAR-T cell therapy research
  • Microscopic Colitis
  • Immunotherapy and Immune Responses

They have published extensively in several journals and venues. Frequent publication venues include:

  • Zenodo (CERN European Organization for Nuclear Research)
  • Gastroenterology
  • The Journal of Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Crohn's and Colitis

Among their recent papers are:

  • "Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity," 2022, Nature Medicine
  • "Human Microbiota Flagellins Drive Adaptive Immune Responses in Crohn's Disease," 2021, Gastroenterology
  • "CD4 + T cell activation and concomitant mTOR metabolic inhibition can ablate microbiota-specific memory cells and prevent colitis," 2020, Science Immunology
  • "Synchronization of mothers and offspring promotes tolerance and limits allergy," 2020, JCI Insight
  • "Remodeling of colon plasma cell repertoire within ulcerative colitis patients," 2023, The Journal of Experimental Medicine

Frequent collaborators in their research include Lennard W. Duck, Albert C. Yeh, Motoko Koyama, Olivia G. Waltner, and Simone A. Minnie. These coauthors have each contributed extensively to joint research efforts.

Best Publications

  • Transforming growth factor-beta induces development of the T(H)17 lineage.

    Paul R. Mangan;Laurie E. Harrington;Darrell B. O'Quinn;Whitney S. Helms

  • The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide

    Sophie Viaud;Sophie Viaud;Fabiana Saccheri;Grégoire Mignot;Takahiro Yamazaki

  • Reciprocal Interactions of the Intestinal Microbiota and Immune System

    Craig L. Maynard;Charles O. Elson;Robin D. Hatton;Casey T. Weaver

  • Experimental models of inflammatory bowel disease

    Charles O. Elson;Ryan Balfour Sartor;Gary S. Tennyson;Robert H. Riddell

  • Late Developmental Plasticity in the T Helper 17 Lineage

    Yun Kyung Lee;Henrietta Turner;Craig L. Maynard;James R. Oliver

  • Anti-interleukin-12 antibody for active Crohn's disease

    Peter J. Mannon;Ivan J. Fuss;Lloyd Mayer;Charles O. Elson

  • Bacterial flagellin is a dominant antigen in Crohn disease

    Michael J. Lodes;Yingzi Cong;Charles O. Elson;Raodoh Mohamath

  • Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice

    L A Dieleman;B U Ridwan;G S Tennyson;K W Beagley

  • Innate lymphoid cells regulate CD4 + T-cell responses to intestinal commensal bacteria

    Matthew R. Hepworth;Laurel A. Monticelli;Thomas C. Fung;Carly G.K. Ziegler

  • Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease

    Richard N. Fedorak;Alfred Gangl;Charles O. Elson;Paul Rutgeerts

  • Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues.

    J Xu-Amano;H Kiyono;R J Jackson;H F Staats

  • Experimental Models of Inflammatory Bowel Disease Reveal Innate, Adaptive, and Regulatory Mechanisms of Host Dialogue With the Microbiota

    Charles O. Elson;Yingzi Cong;Vance J. McCracken;Reed A. Dimmitt

  • Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin.

    C O Elson;W Ealding

  • Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice.

    Charles O. Elson;Yingzi Cong;Casey T. Weaver;Trenton R. Schoeb

  • Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease.

    Stephan R. Targan;Carol J. Landers;Huiying Yang;Michael J. Lodes;Michael J. Lodes

  • Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria–specific CD4+ T cells

    Matthew R. Hepworth;Thomas C. Fung;Thomas C. Fung;Samuel H. Masur;Judith R. Kelsen

  • CD4+ T Cells Reactive to Enteric Bacterial Antigens in Spontaneously Colitic C3H/HeJBir Mice: Increased T Helper Cell Type 1 Response and Ability to Transfer Disease

    Yingzi Cong;Steven L. Brandwein;Robert P. McCabe;A. Lazenby

  • The Th17 Pathway and Inflammatory Diseases of the Intestines, Lungs, and Skin

    Casey T. Weaver;Charles O. Elson;Lynette A. Fouser;Jay K. Kolls

  • Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis

    Michael Mähler;Ian J. Bristol;Edward H. Leiter;Aletha E. Workman

  • Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group.

    S.J.H. van Deventer;C.O. Elson;R.N. Fedorak

Frequent Co-Authors

Yingzi Cong
Yingzi Cong The University of Texas Medical Branch at Galveston
Casey T. Weaver
Casey T. Weaver University of Alabama at Birmingham
Jiri Mestecky
Jiri Mestecky University of Alabama at Birmingham
John P. Sundberg
John P. Sundberg Vanderbilt University
Stephan R. Targan
Stephan R. Targan Cedars-Sinai Medical Center
Warren Strober
Warren Strober National Institute of Allergy and Infectious Diseases
Kenneth W. Beagley
Kenneth W. Beagley Queensland University of Technology
Etty N. Benveniste
Etty N. Benveniste University of Alabama at Birmingham
Jerry R. McGhee
Jerry R. McGhee University of Alabama at Birmingham
Hiroshi Kiyono
Hiroshi Kiyono University of Tokyo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare careers, many of which can be advanced through online degree programs. For those looking to pivot into nursing, accelerated NP programs online offer a fast track to becoming a Nurse Practitioner, combining advanced clinical training with flexible online learning.

If you’re coming from a non-nursing background but aspire to join the nursing field, online ABSN programs for non nurses provide efficient pathways to earn a Bachelor of Science in Nursing. These programs emphasize hands-on skills essential for immunological healthcare roles.

For early-career students or those seeking easier admission routes, exploring the easiest ABSN to get into can be a strategic move. These programs offer a streamlined start toward becoming a registered nurse, ultimately supporting immunology-related professions.

Similarly, LPN programs are a viable option for gaining foundational clinical experience. Identifying which LPN programs are easiest to get into can help prospective students enter the nursing workforce quickly and later transition into more specialized immunology roles.

Best Scientists Citing Charles O. Elson

Trending Scientists

Recently Published Articles